Daniela Moïsi
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 45
- HIV/AIDS Research and Interventions 20
- SARS-CoV-2 and COVID-19 Research 2
- Virology 37
- HIV Research and Treatment 37
- Co-authors
- Mark A. Wainberg (49 shared papers)Bluma Brenner (45 shared papers)Maureen Oliveira (35 shared papers)Michel Roger (9 shared papers)Jean‐Pierre Routy (8 shared papers)Michel Ntemgwa (9 shared papers)Mervi Detorio (8 shared papers)Hugues Charest (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (16 papers)AIDS (11 papers)Journal of Antimicrobial Chemotherapy (5 papers)PLoS ONE (4 papers)Open Forum Infectious Diseases (4 papers)
- Partner nations
- CanadaUnited StatesIvory Coast
In The Last Decade
Daniela Moïsi
64 papers receiving 2.6k citations
Daniela Moïsi's Hit Papers
Peers
Comparison fields: 5 of 83
- Virology 1.5k
- Infectious Diseases 2.0k
- Emergency Medicine 121
- Epidemiology 416
- Hepatology 76
Countries citing papers authored by Daniela Moïsi
This map shows the geographic impact of Daniela Moïsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Moïsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Moïsi more than expected).
Fields of papers citing papers by Daniela Moïsi
This network shows the impact of papers produced by Daniela Moïsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Moïsi. The network helps show where Daniela Moïsi may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniela Moïsi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection Hit paper breakdown → | 2007 | 500 |
| 2 | 2003 | 240 | |
| 3 | 2002 | 178 | |
| 4 | 2006 | 173 | |
| 5 | 2002 | 102 | |
| 6 | 2008 | 102 | |
| 7 | 2004 | 96 | |
| 8 | 2011 | 90 | |
| 9 | 2008 | 72 | |
| 10 | 2017 | 62 | |
| 11 | 2011 | 59 | |
| 12 | 2006 | 53 | |
| 13 | 2010 | 48 | |
| 14 | 2014 | 48 | |
| 15 | 2009 | 47 | |
| 16 | 2004 | 46 | |
| 17 | 2018 | 43 | |
| 18 | 2021 | 42 | |
| 19 | 2011 | 38 | |
| 20 | 2011 | 36 |
About Daniela Moïsi
Daniela Moïsi is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Molecular Biology, having authored 68 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (45 papers), HIV Research and Treatment (37 papers), HIV/AIDS Research and Interventions (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), HIV-related health complications and treatments (6 papers), Biochemical and Molecular Research (4 papers), Hepatitis C virus research (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (2.0k citations), Emergency Medicine (121 citations), Epidemiology (416 citations) and Hepatology (76 citations). Daniela Moïsi has collaborated with scholars based in Canada, United States and Ivory Coast. Frequent co-authors include Mark A. Wainberg, Bluma Brenner, Maureen Oliveira, Michel Roger, Jean‐Pierre Routy, Michel Ntemgwa, Mervi Detorio, Hugues Charest, Dan Turner and Cécile Tremblay. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, AIDS, Journal of Antimicrobial Chemotherapy, PLoS ONE and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.